Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation

Details for Australian Patent Application No. 2001243704 (hide)

Owner Cell Genesys, Inc

Inventors Chen, Yu; Henderson, Daniel R.; Yu, De-Chao

Agent Blake Dawson Waldron

Pub. Number AU-B-2001243704

PCT Pub. Number WO01/72341

Priority 60/192,015 24.03.00 US

Filing date 21 March 2001

Wipo publication date 8 October 2001

Acceptance publication date 27 October 2005

International Classifications

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 015/861 Mutation or genetic engineering - Adenoviral vectors

A61P 035/00 Antineoplastic agents

Event Publications

27 October 2005 Application Accepted

  Published as AU-B-2001243704

23 February 2006 Standard Patent Sealed

15 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001243705

2001243703-Improved process for the preparation of alkylene glycols